Manfred Auer

Manfred Auer is a distinguished inventor based in Moedling, Austria. He has made significant contributions to the field of molecular biology, particularly in the development of methods for identifying inhibitors that affect protein interactions. With a total of 3 patents to his name, Auer's work has implications for both research and therapeutic applications.

Latest Patents

One of Auer's latest patents is a method for the identification of inhibitors of the binding of ARE-containing mRNA and a HuR protein. This invention provides a valuable approach for identifying agents that inhibit the complex formation between these two critical biological components. Another notable patent is an Elisa screening method for inhibitors of human IgE binding to the high-affinity receptor, FcεRIα. This invention is directed towards high-capacity screening of substances that interfere with the attachment of human IgE to its receptor, which is essential for understanding autoimmune disorders and allergies.

Career Highlights

Manfred Auer is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to innovative solutions in healthcare.

Collaborations

Auer has worked alongside notable colleagues such as Nicole-Claudia Meisner and Franz Hammerschmid. Their collaborative efforts have further advanced the research and development of new methodologies in molecular biology.

Conclusion

Manfred Auer's contributions to the field of molecular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in understanding protein interactions and their implications in health and disease.